Related Experiment Video
Updated: Oct 21, 2025

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review
Objective:
Moyamoya disease (MMD) is an intracranial steno-occlusive pathology characterized by progressive narrowing of proximal large vessels, including the terminal internal carotid arteries (ICAs), middle cerebral arteries, or anterior cerebral arteries. Named for the "puff of smoke" appearance of the anomalous vascularization visualized on cerebral angiography, MMD lacks a well-defined etiology, although significant insights have been made, including the identification of a susceptibility gene, RNF213, in humans with the disease. A limitation to advancing the understanding and treatment of MMD has been the lack of experimental animal models that authentically reflect the clinical pathogenesis. In an effort to analyze characteristics of currently available models and identify strategies for future model generation, the authors performed a scoping review of experimental animal models that have been used to study MMD.
Methods:
A systematic search of PubMed, Web of Science, and Scopus was performed to identify articles describing animal models used to study MMD. Additional articles were identified via citation searching. Study selection and data extraction were performed by two independent reviewers based on defined inclusion and exclusion criteria.
Results:
A total of 44 articles were included for full-text review. The methods used to generate these animal models were broadly classified as surgical (n = 25, 56.8%), immunological (n = 7, 15.9%), genetic (n = 6, 13.6%), or a combination (n = 6, 13.6%). Surgical models typically involved permanent ligation of one or both of the common carotid arteries or ICAs to produce chronic cerebral hypoperfusion. Genetic models utilized known MMD or cerebrovascular disease-related genes, such as RNF213 or ACTA2, to induce heritable cerebral vasculopathy. Finally, immunological models attempted to induce vasculitis-type pathology by recapitulating the inflammatory milieu thought to underlie MMD.
Conclusions:
Models generated for MMD have involved three general approaches: surgical, immunological, and genetic. Although each reflects a key aspect of MMD pathogenesis, the failure of any individual model to recapitulate the development, progression, and consequences of the disease underscores the importance of future work in developing a multietiology model.
Insights
This review of Moyamoya disease animal models found surgical, genetic, and immunological approaches are used. No single model fully replicates the disease, highlighting the need for multietiology models.
Area of Science:
- Neurology
- Vascular Biology
- Genetics
Background:
- Moyamoya disease (MMD) is a progressive intracranial steno-occlusive disease affecting major cerebral arteries.
- The exact cause of MMD is unknown, but genetic factors like RNF213 are implicated.
- A significant hurdle in MMD research is the lack of animal models that accurately mimic human disease pathogenesis.
Purpose of the Study:
- To conduct a scoping review of existing experimental animal models for Moyamoya disease.
- To analyze the characteristics and methodologies of current MMD animal models.
- To identify strategies for developing improved future MMD models.
Main Methods:
- Systematic literature search of PubMed, Web of Science, and Scopus databases.
- Inclusion and exclusion criteria were applied by two independent reviewers.
- Citation searching was used to identify additional relevant articles.
Main Results:
- 44 articles were included in the review.
- Animal models were generated using surgical (56.8%), immunological (15.9%), genetic (13.6%), or combined (13.6%) approaches.
- Surgical models induced chronic cerebral hypoperfusion, genetic models used disease-related genes, and immunological models mimicked vasculitis.
Conclusions:
- Current MMD animal models employ surgical, immunological, or genetic strategies.
- Each model captures certain aspects of MMD but none fully recapitulate the disease's development and progression.
- Future research should focus on developing multietiology models to better understand and treat Moyamoya disease.
More Related Videos
09:08Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area
Published on: February 2, 2017
10:30Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice
Published on: October 20, 2016